Subventions financées

Caring for a family member with a neurodevelopmental disability (NDD) can be challenging, often leading to high levels of anxiety and depression.

Glioblastoma Multiforme (GBM) is the most common and aggressive brain tumour in adults.

The Histology Innovation Platform at McGill University is a specialized facility that helps scientists study the brain at a cellular level to better understand neurological diseases like Alzheimer’s, brain cancer, and epilepsy.

Challenge: ALS (amyotrophic lateral sclerosis) is an incurable and invariably fatal motor neuron (MN) disease.

Optogenetics, defined as a technique where light-sensitive genes are introduced into brain cells to control their activity with light, allows researchers to precisely control nerve cell communication thereby, transforming brain research.

In Alzheimer’s disease (AD), the pathogenic amyloid-beta protein accumulates in the brain parenchyma and vessel walls.

Every day, over 350 Canadians are diagnosed with dementia, and this number is expected to grow rapidly.

Brain cancer is rarely curative and urgently needs novel transformative treatments.

Depression is a leading cause of disability, with a large proportion of treatment-resistant patients. Recent studies have implicated reduced brain inhibition in human depression from a specific neuron type (SST), and new pharmacology boosting this reduced inhibition led to antidepressant and pro-cognitive effects in rodents.

Amyotrophic lateral sclerosis (known as ALS or Lou Gehrig’s disease) is a debilitating disease that causes loss of control over muscles and leads to death quickly after diagnosis.